Cancer cell membrane fused liposomal platinum(<scp>iv</scp>) prodrugs overcome cisplatin resistance in esophageal squamous cell carcinoma chemotherapy-Reference-Cited by-同舟云学术

Cancer cell membrane fused liposomal platinum(iv) prodrugs overcome cisplatin resistance in esophageal squamous cell carcinoma chemotherapy

Published:2023 Issue:47 Volume:11 Page:11384-11393
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Zhang Shuaibing¹,Jiang Wei¹^ORCID,Wang Shenghui¹,Song Kexu¹,Ge Mengyue¹,Zhang Lirong²,Yan Xiyun¹³,Jiang Bing¹^ORCID

Affiliation:

1. Nanozyme Medical Center, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China

2. State Key Laboratory of Esophageal Cancer Prevention &Treatment, Henan, 450001, China

3. CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China

Abstract

EMLipoPt(iv) was designed to combat cisplatin resistance in esophageal squamous cell carcinoma (ESCC) by enhancing platinum uptake and minimizing drug inactivation through a fusion of ESCC cell membrane with liposomal Pt(iv) prodrugs.

Funder

National Natural Science Foundation of China

Postdoctoral Research Foundation of China

Institute of Medical Science, University of Tokyo

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2023/TB/D3TB01997G

Reference35 articles.

1. Global cancer statistics, 2012

2. Clinical and translational advances in esophageal squamous cell carcinoma

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

4. Identification of genomic alterations in oesophageal squamous cell cancer

5. Advances in the Theranostics of Oesophageal Squamous Carcinoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Pt(IV) complexes containing salvigenin ligand reverse cisplatin-induced resistance by inhibiting Rap1b-mediated cancer cell stemness in esophageal squamous cell carcinoma treatments;Bioorganic Chemistry;2024-06